Literature DB >> 1689937

Immunohistochemical and ultrastructural localization of T antigen in ovarian tumors.

M Ghazizadeh1, T Oguro, Y Sasaki, K Aihara, T Araki, G F Springer.   

Abstract

Thomsen-Friedenreich (T) antigen, the immediate precursor antigen of the human blood group MN system, has been found in many carcinomas, but it is suppressed in normal tissues and nonmalignant diseases. Using a monoclonal antibody specific for the T epitope and an indirect immunoperoxidase technique at light and electron microscopic levels, the authors studied the expression of T antigen and its potential diagnostic value in ovarian tumors. Among 30 serous and mucinous ovarian cystadenocarcinomas, 20 (67%) were positive and 10 (33%) were negative for T antigen. In carcinomas, positive rates increased in parallel with the tumor grade and were 37%, 75% and 80% for grade 1, 2, and 3 tumors, respectively. Of the nine patients with metastasis, seven (78%) had positive and two had negative reactions in their primary and metastatic tumors. T antigen staining was observed at the intraluminal cell surfaces and peripheral cell membranes. The ultrastructural localization of T antigen revealed electron-dense reaction products at the cell surface and microvillous surfaces. Of the ten benign ovarian tumors, three (30%) were weakly positive and seven (70%) were negative for T antigen. These findings indicate a positive correlation between the presence of immunoreactive T antigen and conventional unfavorable prognostic indicators in ovarian carcinoma. The surface location of T antigen suggests that it may have a functional role at the cell membrane and the membrane may be involved in secretion (shedding) of T antigen. Detection of T antigen may be a useful marker of prognosis in ovarian carcinoma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689937     DOI: 10.1093/ajcp/93.3.315

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

Review 1.  Cancer vaccines and carbohydrate epitopes.

Authors:  Jamie Heimburg-Molinaro; Michelle Lum; Geraldine Vijay; Miten Jain; Adel Almogren; Kate Rittenhouse-Olson
Journal:  Vaccine       Date:  2011-10-01       Impact factor: 3.641

2.  Differential expression of the cancer associated antigens T (Thomsen-Friedenreich) and Tn to the skin in primary and metastatic carcinomas.

Authors:  J Kanitakis; I al-Rifai; M Faure; A Claudy
Journal:  J Clin Pathol       Date:  1998-08       Impact factor: 3.411

Review 3.  The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression.

Authors:  Lu-Gang Yu
Journal:  Glycoconj J       Date:  2007-04-25       Impact factor: 2.916

4.  DNA-cytophotometry and immunocytochemistry in ovarian tumours of borderline malignancy and related peritoneal lesions.

Authors:  B C Padberg; H E Stegner; S von Sengbusch; H Arps; S Schröder
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

5.  p53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer.

Authors:  Sabine Heublein; Sabina K Page; Doris Mayr; Nina Ditsch; Udo Jeschke
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-02       Impact factor: 4.553

6.  Use of sialylated or sulfated derivatives and acrylamide copolymers of Gal beta 1,3GalNAc alpha- and GalNAc alpha- to determine the specificities of blood group T- and Tn-specific lectins and the copolymers to measure anti-T and anti-Tn antibody levels in cancer patients.

Authors:  Y Chen; R K Jain; E V Chandrasekaran; K L Matta
Journal:  Glycoconj J       Date:  1995-02       Impact factor: 2.916

7.  Tumor-associated glycans and their role in gynecological cancers: accelerating translational research by novel high-throughput approaches.

Authors:  Tatiana Pochechueva; Francis Jacob; Andre Fedier; Viola Heinzelmann-Schwarz
Journal:  Metabolites       Date:  2012-11-14

8.  Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis.

Authors:  Swetha Tati; John C Fisk; Julia Abdullah; Loukia Karacosta; Taylor Chrisikos; Padraic Philbin; Susan Morey; Diala Ghazal; Fatma Zazala; Joseph Jessee; Sally Quataert; Stephen Koury; David Moreno; Jing Ying Eng; Vladislav V Glinsky; Olga V Glinskii; Muctarr Sesay; Anthony W Gebhard; Karamveer Birthare; James R Olson; Kate Rittenhouse-Olson
Journal:  Neoplasia       Date:  2017-08-19       Impact factor: 5.715

Review 9.  Altered tumor-cell glycosylation promotes metastasis.

Authors:  Irina Häuselmann; Lubor Borsig
Journal:  Front Oncol       Date:  2014-02-13       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.